NEWARK, Calif., Apr 16, 2015 (GLOBE NEWSWIRE via COMTEX) — StemCells, Inc. STEM, +1.59% a leading stem cell company developing novel cell-based therapeutics for treating diseases of the central nervous system with high unmet medical need, announced today that it

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone